Style | Citing Format |
---|---|
MLA | Shakibay Senobari Z, et al.. "Chromone-Embedded Peptidomimetics and Furopyrimidines As Highly Potent Sars-Cov-2 Infection Inhibitors: Docking and Md Simulation Study." BMC Research Notes, vol. 16, no. 1, 2023, pp. -. |
APA | Shakibay Senobari Z, Masoumian Hosseini M, Teimouri MB, Rezayan AH, Samarghandian S, Hekmat A (2023). Chromone-Embedded Peptidomimetics and Furopyrimidines As Highly Potent Sars-Cov-2 Infection Inhibitors: Docking and Md Simulation Study. BMC Research Notes, 16(1), -. |
Chicago | Shakibay Senobari Z, Masoumian Hosseini M, Teimouri MB, Rezayan AH, Samarghandian S, Hekmat A. "Chromone-Embedded Peptidomimetics and Furopyrimidines As Highly Potent Sars-Cov-2 Infection Inhibitors: Docking and Md Simulation Study." BMC Research Notes 16, no. 1 (2023): -. |
Harvard | Shakibay Senobari Z et al. (2023) 'Chromone-Embedded Peptidomimetics and Furopyrimidines As Highly Potent Sars-Cov-2 Infection Inhibitors: Docking and Md Simulation Study', BMC Research Notes, 16(1), pp. -. |
Vancouver | Shakibay Senobari Z, Masoumian Hosseini M, Teimouri MB, Rezayan AH, Samarghandian S, Hekmat A. Chromone-Embedded Peptidomimetics and Furopyrimidines As Highly Potent Sars-Cov-2 Infection Inhibitors: Docking and Md Simulation Study. BMC Research Notes. 2023;16(1):-. |
BibTex | @article{ author = {Shakibay Senobari Z and Masoumian Hosseini M and Teimouri MB and Rezayan AH and Samarghandian S and Hekmat A}, title = {Chromone-Embedded Peptidomimetics and Furopyrimidines As Highly Potent Sars-Cov-2 Infection Inhibitors: Docking and Md Simulation Study}, journal = {BMC Research Notes}, volume = {16}, number = {1}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Shakibay Senobari Z AU - Masoumian Hosseini M AU - Teimouri MB AU - Rezayan AH AU - Samarghandian S AU - Hekmat A TI - Chromone-Embedded Peptidomimetics and Furopyrimidines As Highly Potent Sars-Cov-2 Infection Inhibitors: Docking and Md Simulation Study JO - BMC Research Notes VL - 16 IS - 1 SP - EP - PY - 2023 ER - |